Characterisation of Antifungal Prophylaxis and Therapy Among Inpatients With Haematological Malignancies in Non-Research Clinical Setting: A Multicentre Italian Experience. [PDF]
Marianna C +29 more
europepmc +1 more source
Fungal colonization and CLAD in lung transplant recipients: Implications for antifungal prophylaxis and graft survival. [PDF]
Dhanani Z, Albaba I, Anjum F.
europepmc +1 more source
Evaluation of Posaconazole Therapeutic Drug Monitoring for Antifungal Prophylaxis in Hematology Patients at a Tertiary Referral Center. [PDF]
Ashok A +5 more
europepmc +1 more source
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin. [PDF]
Atas U +26 more
europepmc +1 more source
Comparative study of liposomal amphotericin B, posaconazole, and micafungin for primary antifungal prophylaxis in pediatric patients with acute leukemia. [PDF]
Gottschlich AS +3 more
europepmc +1 more source
Correction: Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC. [PDF]
Salmanton-García J +6 more
europepmc +1 more source
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center. [PDF]
Grimaldi F +14 more
europepmc +1 more source
Antifungal prophylaxis in high-risk patients with hematologic malignancy: a comparison of practice and guidelines in Türkiye. [PDF]
Güzel Tunçcan Ö +10 more
europepmc +1 more source
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL). [PDF]
Pagano L +9 more
europepmc +1 more source
Current trends on antifungal prophylaxis in solid organ transplantation: a study from ESCMID-EFISG, ESCMID-ESGICH, SITA, and SEIMC-GESITRA-IC. [PDF]
Salmanton-García J +6 more
europepmc +1 more source

